Strategic Overview

iGENETECH develops MoiM MTB, a decentralized molecular test for TB diagnosis.

Innovation Portfolio

MoiM MTB
Category: DIAGNOSIS Stage: Late Stage

Moderate-throughput molecular platform for MTBC detection optimized for district laboratory settings. Balances performance and simplicity for intermediate complexity environments.

Molecular Sputum

Key Milestones

MoiM MTB decentralized molecular test
District-level capability
Sputum-based testing
Approximately 2-hour turnaround